Trial Profile
Combination Therapy of Insulin Glargine and Sitagliptin in Patients With Type 2 Diabetes Not Adequately Controlled by a Previous Treatment With Metformin and Either Insulin Glargine or Sitagliptin
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms EASIE Extension; EXT_EASIE
- Sponsors Sanofi
- 21 Jul 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
- 06 May 2016 New trial record
- 20 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.